Programme

​Content and Speakers

SYMPOSIUM PROGRAM
Friday September 29, 2017
Time: 08.30-17.00

8.30-9.00:         Breakfast

9.00-9.15       Morten Schiodt:
Welcome and introduction

9.15-9.45       Stefano Fedele:
What is Medication Related Osteonecrosis (MRONJ)?  
Epidemiology, Definition, Classification, Staging Non-exposed MRONJ: How to identify?  Time to onset of ONJ
Comments or questions from the expert panel and the audience

9.45-10.15    Sven Otto:
Clinical Manifestations of MRONJ Pathogenesis
Local and systemic risk factors, Importance of infections, Cell Culture findings
Comments or questions from the expert panel and the audience

10.15-10.35:  Coffee Break

10.35-10.45    Sven Otto:
  Animal Studies
 Comments or questions from the expert panel and the audience

10.45-11.15    Roman Guggenberger:
Imaging, Radiologic features, Cone Beam Tomography, CT Scan, Scintigraphy, MR
Comments or questions from the expert panel and the audience

11.15-11.45    Ourania Nicolatou-Galitis:
Early MRONJ -  Importance of periodontal disease
Comments or questions from the expert panel and the audience

11.45-12.15    Morten Schiodt/Sven Otto:
Part 1. Treatment of MRONJ
Comments or questions from the expert panel and the audience

12.15-13.00:     Lunch

13.00-13.15    Morten Schiodt/Sven Otto:
Part 2. Treatment of MRONJ
Comments or questions from the expert panel and the audience

13.15-13.45    Thomas Kofod:
Computer assisted 3D planning of surgical treatment of MRONJ
Surgical methods for reconstruction of large defects
Comments or questions from the expert panel and the audience

13.45-14.00    Alberto Bedogni:
Custom-made prostheses for mandible reconstruction in MRONJ patients.
Comments or questions from the expert panel and the audience

14.00-14.15    Morten Schiodt:
Tooth extraction in patients on antiresorptive treatment: Can we control the risk of MRONJ? When? How? Results?
Comments or questions from the expert panel and the audience

14.15-14.30    Alberto Bedogni:
Drug holiday:  Should the antiresorptive treatment be paused or stopped when MRONJ is diagnosed? What do we know today?
Comments or questions from the expert panel and the audience

14.30-15.00:    Coffee break

15.00-15.15    Alberto Bedogni:
New drugs: Tyrosine Kinase Inhibitors and other new drugs: What is their role in MRONJ?
Comments or questions from the expert panel and the audience

15.15-15.30    Ourania Nicolatou-Galitis:
Prevention of MRONJ
Comments or questions from the expert panel and the audience

15.30-15.45    Ourania Nicolatou-Galitis:.
Education of health care providers and patients.
Comments or questions from the expert panel and the audience

15.45-16.45    Round table discussion:
Sven Otto, Alberto Bedogni, Ourania
Nicolatou-Galitis, Stefano Fedele, Roman Guggenberger and Thomas Kofod. 
Moderator: Morten Schiodt.  

1. Patient cases to discuss.
2. What are the key research questions to solve now?
3. How do we proceed? Research, Organization, Education, etc.

16.45-17.00    Summary and closing the symposium

Responsible editor